ATH 33.3% 0.4¢ alterity therapeutics limited

I am in ... great expectations on this one., page-7

  1. 1,640 Posts.
    lightbulb Created with Sketch. 143
    Pbt2 on market for HD could well just be the same as being in the market for AD.. Just will be prescribed off label..

    there's probably good reason fda being cautious currently and ensuring all boxes are ticked

    There's enough evidence for ad sufferers to want to try pbt2 as soon as it's made available..
    Last edited by m123456: 20/01/16
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.